Why is NVAX Down Today?

NVAX
$10.20
▼ -6.34% ($-0.65)
Last updated: Nov 11, 2026 2:30 PM ET

About Novavax Inc

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond ...

Sector: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap: $1.54B
Forward P/E: 46.8
52-Week Range: $6.20 - $13.39
Employees: 1,992

Overall Confidence: 67%

67% Confident

Based on news, social sentiment, options activity, and sector analysis

SECTOR 65% Confidence
🎯 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector moving together
This appears to be a sector-wide move. The BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector is down 4.1% on average.

✅ Move Confirmation

MODERATE VOLUME 1.3x average volume

NORMAL - This move is backed by significant volume and appears sustainable.

📍 Sector Context

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -4.1%

This appears to be a sector-wide move. Most BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) stocks are moving in the same direction.

Market Comparison

NVAX is significantly underperforming the market (-6.0% vs SPY)
S&P 500
SPY
-0.37%
Nasdaq 100
QQQ
-0.68%
NVAX
This Stock
-6.34%
vs S&P 500: -5.97%
vs Nasdaq: -5.66%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, NVAX is expected to trade between:
$9.89 - $10.40

Key Level to Watch

$9.69 support
Watch for breakdown below $10.20

Quick Trade Ideas

Options strategies to consider for NVAX's -6% move

📊

No Options Available

NVAX doesn't have listed options or options data is currently unavailable.

Try another stock in our Options Calculator →
Disclaimer: These are educational examples only, not investment advice. Options involve significant risk including total loss of premium. Prices shown are estimates and may differ from actual market prices. Always do your own research and consider your risk tolerance.

🔔 Get NVAX Alerts

We'll notify you when NVAX's trend changes or a new signal fires.

Last updated: Nov 11, 2026 2:30 PM (-347 minutes ago)
Data refreshes every 30 minutes during market hours

Options Market Insight

Bullish
Options Sentiment
0.39
Put/Call Ratio
145.6%
Implied Volatility
Call Volume: 17,236
Put Volume: 6,717
Total: 23,953
Unusual Activity: $10 CALL (1,368 vol) $11 CALL (1,168 vol)

Historical Context

NVAX has moved more than 3.0% down on 52 occasions in the past year.

48.1%
Continuation Rate
25/52 times continued down
0.0%
Avg Next Day Change
After similar down moves
Last similar move: Nov 05, 2026 (-8.2%) → Next day: +10.2%

Frequently Asked Questions

Why is NVAX stock down today?

This appears to be a sector-wide move. The BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector is down 4.1% on average.

Is NVAX stock a buy or sell right now?

Based on current analysis, NVAX shows 67% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →

What is the NVAX stock price target?

NVAX is currently trading at $10.20. Based on today's momentum, the expected short-term range is $9.89 - $10.40. See long-term price prediction →

Will NVAX stock continue falling?

Our analysis shows a 45% probability that NVAX's move continues in the next 1-3 days. Key level to watch: $9.69 (support).

Is NVAX stock oversold or overbought?

NVAX's RSI (Relative Strength Index) is currently at 47.8. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for NVAX stock?

NVAX's 10-day momentum indicator is at 0.18. Positive momentum - the stock has mild upward pressure supporting the current trend.

Is NVAX outperforming or underperforming the market?

NVAX (-6.34%) is currently significantly underperforming the market (-6.0% vs SPY). Today, the S&P 500 (SPY) is down -0.37%, and Nasdaq (QQQ) is down -0.68%.

What does MACD indicate for NVAX?

NVAX's MACD (-0.12) is currently below the signal line (-0.11), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 25.4) is strong.

Is NVAX in an uptrend or downtrend?

Based on moving average analysis, NVAX is in a bearish trend. The price ($10.20) is trading below both the 20-day SMA ($10.57) and 50-day SMA ($10.61). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL